Cellular pharmacology of 2',3'-dideoxy-2',3'-didehydrothymidine, a nucleoside analog active against human immunodeficiency virus.

Documenti analoghi

• Mutants of feline immunodeficiency virus resistant to 2',3'-dideoxy-2',3'-didehydrothymidine.
  di: Zhu, Y Q, et al.
  Pubblicazione: (1996)
• Effects of drugs on 2',3'-dideoxy-2',3'-didehydrothymidine phosphorylation in vitro.
  di: Hoggard, P G, et al.
  Pubblicazione: (1997)
• In vitro bone marrow toxicity of nucleoside analogs against human immunodeficiency virus.
  di: Inoue, T, et al.
  Pubblicazione: (1989)
• The synthesis of branched-chain 3'-C-cyanomethyl-2',3'-dideoxy sugar nucleosides of adenine as potential inhibitors of the human immunodeficiency virus.
  di: Halmos, T, et al.
  Pubblicazione: (1989)
• Metabolism of 2′,3′-Dideoxy-2′,3′-Didehydro-β-l(−)-5-Fluorocytidine and Its Activity in Combination with Clinically Approved Anti-Human Immunodeficiency Virus β-d(+) Nucleoside Analogs In Vitro
  di: Dutschman, Ginger E., et al.
  Pubblicazione: (1998)